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ABSTRACT 
 Neutrophil chemotaxis and intercellular signaling via diffusible molecules are vital 
physiological processes in the human body.  The two processes play a role in diseases 
and disorders such as rheumatoid arthritis, tumorigenesis, and sepsis.  A better 
understanding of the two processes will aid in the development of new therapeutics.  
However, conventional methods used to study chemotaxis and intercellular signaling 
have limited control over the microenvironment.  Control over the microenvironment is 
required to generate multiple independent gradients and modulate spatial and temporal 
presentation of signaling molecules, which is needed to study neutrophil chemotaxis 
and intercellular signaling respectively.  Microfluidic platforms have the potential to 
study these biological processes due to the inherent control over the microenvironment.  
Here, we used PDMS-based microfluidic platforms to study neutrophil chemotaxis and 
intercellular signaling.  The microfluidic platforms were used to generate stable 
opposing linear gradients of the intermediary chemoattractants LTB4 and IL-8.  In the 
opposing linear gradients, neutrophils exhibited an oscillatory behavior migrating 
between the two chemoattractant maxima.  Finally, a microfluidic platform to study 
intercellular signaling via diffusible molecules was developed and validated.  The 
microfluidic platforms developed and used here enable detailed study of important 
biological phenomena such as neutrophil chemotaxis and intercellular signaling via 
diffusible molecules. 
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Chapter 1 
INTRODUCTION 
1.1 Challenges studying cell signaling and migration 
Cell behavior is modulated based on the specific signals a cell receives.  These 
signals can be broadly classified as (i) signals from other cells, (ii) interactions with the 
extracellular matrix, and (iii) systemic factors.  Cell-cell interactions are mediated 
through gap junctions directly connecting the cytoplasms of two cells, direct contact 
between the two cells through adherens, and long range signaling via diffusible 
molecules (1).  Cell-cell interactions have been shown to be critical in many biological 
processes such as immune function (2, 3), tissue and organ development (4), and 
tumor growth (5-7).  Cellular interactions with the extracellular matrix control various 
signal transduction processes that affect cell differentiation, cell survival, and the 
expression of various phenotypes (8).  Systemic factors, such as inflammation, can play 
a role in the behavior of immune cells (9).  Together these signals create a complex 
input that regulates and directs cell behavior.   
Many techniques and methods exist to study cellular behavior.  However, many 
conventional methods cannot discern a specific response from a specific signal due to 
the lack of control over the microenvironment (10).  Specifically, cell migration and 
intercellular signaling via diffusible molecules require precise control over the 
microenvironment.  Cell migration is conventionally studied using under agarose 
assays, the Zigmond chamber, or micropipette assays (10, 11).  However, these 
conventional platforms suffer from several limitations.  Specifically, in the under agarose 
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assay challenges exist in obtaining reproducible, controllable, and stable linear 
gradients.  The Zigmond chamber is unable to generate multiple independent gradients 
(12), and in the micropipette assay it is difficult to relate specific cell response with 
distinct gradient characteristics.  While these conventional platforms have enabled 
many studies on cell migration, the use of a platform with more control over the 
microenvironment is necessary for further studies. 
Intercellular signaling via diffusible molecules allows cells to communicate over 
long distances.  Studying the cellular response to diffusible signals requires culture of 
multiple cell types and the presentation of natural signaling gradients (10).  The 
conventional methods to study signaling via diffusible molecules are the transwell 
assay, bolus transfer of conditioned medium, and co-culture experiments (10).  These 
conventional methods are limited by the control over spatial and temporal presentation 
of signaling molecules.  For example, a bolus transfer of conditioned medium disrupts 
the natural signaling gradient that occurs in vivo.  Hence, the development of a platform 
with control over spatial and temporal presentation of the signaling molecules is 
required for a better understanding of cell behavior in the presence of diffusible 
signaling molecules. 
1.2 Biological assays using microfluidic platforms 
Advances in microfabrication techniques have led to the use of microfluidic 
platforms for biological applications.  The relevant biological length scale, combinatorial 
capabilities, and control over fluid dynamics give microfluidic platforms key advantages 
compared to macroscale devices (13).  These advantages have been utilized by 
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developing microfluidic platforms for studying enzymatic reactions (14, 15), cell sorting 
(16), and cell culture (17-19).  The combinatorial capabilities and small sample size of 
these platforms are well suited for studying problems such as antibiotic screening (20), 
protein crystallization (21), and defects in the immune response (22, 23).  Control over 
mass transport of nutrients has allowed studies on tissue engineering and even the 
growth of blood vessels on a microfluidic platform (24, 25).  Clearly, the potential for 
microfluidic platforms in biotechnology is limitless. 
More specifically, microfluidic platforms have shown a great potential as 
platforms for biological assays.  Microfluidic platforms have been used in numerous cell 
migration assays (23, 26-35).    Huang and coworkers developed a platform to study the 
real time interactions of metastatic breast cancer and macrophage cells via paracrine 
signaling (36).  Single cell analysis has been performed on immune cells to determine 
heterogeneity (37, 38).  A platform was developed to study the affect of soluble factor 
gradients on stem cell differentiation (39).  Further, cell mechanics have been studied 
using microfluidic platforms with cantilevers (40-42).  Even intracellular signaling 
mechanisms have been probed using microfluidic platforms (26).  Hence, microfluidic 
platforms have become increasingly useful as tools to study cell biology. 
1.3 Overall objectives 
The overall objective of our research is to develop and use microfluidic platforms 
to study fundamental biological processes.  Specifically, cell migration and intercellular 
signaling studies can be performed using the developed microfluidic platforms.  A better 
understanding of these biological processes can help to treat problems with immune 
function, tissue and organ development, and tumorigenesis.  However, to study these 
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biological processes a tool is required that can generate stable gradients, control spatial 
and temporal presentation of molecules, and separate specific response from specific 
signals .  Microfluidic platforms can perform these tasks because the platforms allow for 
precise control over the microenvironment.   On the other hand, conventional platforms 
cannot perform these tasks due to the inherent lack of control over the 
microenvironment.  This thesis describes the study of neutrophil chemotaxis and cell-
cell communication using microfluidic platforms.  Chapter 2 discusses the study of 
neutrophil chemotaxis using a microfluidic platform with a ‘Y-shaped’ design.  The ‘Y-
shaped’ design enables rapid generation of stable linear concentration gradients.  Using 
this platform, neutrophil response to linear gradients of multiple chemoattractants was 
examined.  Chapter 3 discusses the development of a microfluidic platform to study 
intercellular signaling via soluble molecules.  Cells are patterned independently in 
specific channels by positive pressure in the developed platform.  Next, intercellular 
signaling occurs when a soluble molecule is secreted by a cell and diffuses from 
channel to channel.  The resulting phenotypic change from the soluble molecule is then 
characterized using an inverted microscope.  Finally, Chapter 4 summarizes the key 
conclusions from this work and describes the future directions of this project. 
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Chapter 2 
NEUTROPHIL CHEMOTAXIS 
2.1. Introduction 
The acute inflammatory response is responsible for the removal of pathogens 
and cellular debris from affected tissues (1). Neutrophils in particular provide the most 
immediate and prolific response among leukocytes; however, these cells can also 
cause host damage if their effector functions are not controlled, resulting in chronic 
inflammatory disorders such as pulmonary emphysema, rheumatoid arthritis, chronic 
obstructive pulmonary disease and asthma (2-8). Recent studies suggest that defects in 
neutrophil trafficking may also contribute to these conditions. Abnormal neutrophil 
infiltration and/or accumulation is commonly observed in studies of affected patients, 
resulting in immunodeficiency, improper inflammatory resolution and other clinical 
disorders (9-15). An improved understanding of neutrophil physiology, particularly the 
mechanism of cell trafficking during the immune response, could assist in the 
development of better therapeutic strategies against these diseases. 
Neutrophils are highly motile cells that can perform chemotaxis toward a number 
of chemicals including (i) N-formylated peptides generated by microbes; (ii) a 
glycoprotein fragment, C5a, produced by the complement system; (iii) leukotriene B4 
(LTB4) secreted by sentinel mast cells; and (iv) chemokines like interleukin-8 (IL-8) and 
macrophage inflammatory protein 2 (MIP-2).  The N-formylated peptides (fMLP) and 
complement fragments (C5a) are generally referred to as end-target chemoattractants 
due to their proximity to the site of infection, whereas LTB4, IL-8, and MIP-2 are 
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generally referred to as intermediary chemoattractants.  Each chemoattractant binds a 
unique subset of G protein-coupled receptors (GPCRs) on the cell surface, triggering 
the localization of key regulators to either the front or back of the cell (16-23). This 
intrinsic gradient dictates the subsequent direction of locomotion via localized 
cytoskeletal extension and contraction. In the extravascular environment, however, 
activated neutrophils can encounter multiple superimposed attractant gradients that 
possess both spatial and temporal variation. Successful navigation requires the 
appropriate integration and prioritization of these chemotactic cues. 
Previous studies have shown that neutrophils selectively migrate toward fMLP 
and C5a even when opposing gradients of IL-8 or LTB4 are present (24, 25). These 
results suggest that the cells can distinguish between different attractant species, and 
will migrate towards those produced closest to the site of infection. While the 
mechanism for this signaling hierarchy is not known, current results suggest that the two 
classes of chemicals operate along different signal transduction pathways altogether - in 
particular, chemotaxis to the end-target attractants fMLP and C5a involves the p38 
mitogen-activated protein kinase (p38 MAPK) pathway, whereas chemotaxis towards 
IL-8, LTB4, and MIP-2 likely involves the phosphatidylinositol-3-OH (PI3K)/phosphatase 
and tensin homolog (PTEN) pathway (26-28). The crosstalk between these pathways is 
thought to involve PTEN, a known PI3K antagonist, via p38 MAPK-mediated 
recruitment to the cell circumference (29-31). Consequently, in the presence of any end-
target attractant, chemotaxis toward the intermediary attractants is suppressed. 
The prioritization of end target attractants is consistent with the functional 
requirement of convergence on immune targets; by contrast, it is much less obvious 
11 
 
how different intermediary attractants should jointly affect neutrophil behavior. To study 
this particular problem, Foxman et al. conducted a number of studies with primary cells 
using the under-agarose chemotaxis assay (25, 32). Interestingly, they found that in 
opposing linear gradients of IL-8 and LTB4, activated cells tended to migrate toward the 
more distant attractant source and away from the more proximal one, independent of 
the attractant species. Similarly, given IL-8 and LTB4 point sources presented at an 
offset, cells were observed to vectorially integrate the local chemoattractant gradients, 
moving in the direction of their vector sum. Extrapolating from these observations, 
Foxman and others suggested that provided sufficient time, the cells could migrate back 
and forth between the two maxima, yet this experimental result was never confirmed. In 
addition, attempted mathematical models have been limited primarily by the lack of 
experimental data characterizing such a response. To this end, it was necessary to 
develop improved protocols and a solid platform for the generation of stable opposing 
chemoattractant gradients over an extended period of time. 
With the advent of microfluidic technologies, quantitative studies of cell behavior 
have become easier to perform.  Microfluidic platforms allow for stable, reproducible, 
rapidly-forming concentration gradients with linear or other complex profiles. This 
precise control over the chemical distribution within microchannels or chambers makes 
them particularly well suited for chemotaxis assays. For instance, Jeon et al. 
demonstrated neutrophil chemotaxis in a microfluidic device by generating IL-8 
gradients with different shapes (33). Using a "christmas tree" device, they characterized 
neutrophil responses to linear, "hill-type", and "cliff-type" gradients of IL-8, as well as the 
effect of gradient steepness versus mean attractant concentration (34). In another 
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study, Herzmark et al. developed a platform to generate exponential attractant 
gradients, or gradients with fixed ∆C/C, as a way to characterize neutrophil responses 
against varying ambient concentration (35). This allowed them to confirm that cells 
exhibit optimal sensitivity at ambient concentrations close to the Kd of the receptors. 
Meanwhile, Lin et al. used their microfluidic device to show that high concentrations of 
IL-8 can also cause fugetaxis in activated cells (36), further attesting to the non-trivial 
nature of their chemotactic response. 
Other microfluidic studies of neutrophils have involved the use of "open chamber" 
devices to study neutrophil desensitization (37), devices that constrain cell migration 
with bifurcating or constricted channels to characterize cell sensitivity (38, 39), an 
arrayed device used to diagnose patients and study intracellular processes (40, 41), 
and more complex devices to analyze how neutrophils respond to dynamic gradients 
(42, 43). While neutrophil migration in opposing IL-8 and LTB4 gradients have also been 
studied using microfluidic devices in the past (24, 44, 45), these efforts have focused 
particularly on the prioritization between these chemicals in the short term, such as 
whether LTB4 can influence chemotaxis towards IL-8 (44). In this work, we perform a 
detailed study of neutrophil migration toward distant intermediary attractant sources, 
and ask what would happen if the duration of these experiments was prolonged. For this 
purpose, we employed a "Y-shaped channel" design in our device, which enables the 
rapid generation of stable linear gradients - this "Y type" design has also been used to 
study chemotaxis in T cells (46) and signaling pathways in differentiated HL60 cells, 
which are widely known to resemble neutrophils (47).   
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2.2. Materials and methods 
2.2.1. Microfluidic device fabrication  
The microfluidic device was comprised of a molded poly(dimethysiloxane) 
(PDMS, General Electric RTV 650 Part A/B) slab bonded to a glass substrate. High 
resolution printing (5080 dpi) was used to print the mask with the design pattern on a 
transparency film. The mask was used to fabricate 50 µm high SU-8 2050 photoresist 
(Microchem) features on a silicon wafer via photolithography. PDMS molds with 
embossed channels were fabricated using soft lithography by curing the pre-polymer on 
the silicon master for 2 hours at 70ºC. The PDMS replica was then peeled off the silicon 
master. Inlets and outlets for the fluids and cells were created in PDMS using a steel 
punch. The surface of the PDMS replica and a clean glass coverslip (Fisher Scientific) 
were treated with air plasma for 90 seconds (Model PDC-001, Harrick Scientific) and 
irreversibly bonded to complete the device assembly (Figure 2.1). The device inlets 
were then connected to 1 mL syringes (BD Biosciences) with 23 G ¾ size needles (BD 
Biosciences) via PTFE tubing (Cole-Parmer). All syringes were calibrated and pushed 
by a constant pressure syringe pump (Harvard Apparatus). Prior to each experiment, 
the device was also loaded with fibronectin (25µg/mL, Invitrogen) and kept at room 
temperature for 30 minutes to promote optimal cell adhesion. 
2.2.2. Gradient formation 
The concentration gradients across the microchannel were verified by infusing 
fluorescently-labeled solution (Fluorescein, Sigma Aldrich) from one inlet and an 
unlabeled solution from the other inlet of the device (Figure 2.2). Diffusive mixing 
across the interface of the laminar streams led to formation of the gradient. Fluorescent 
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images were acquired at different locations along the channel using a FITC filter on the 
Zeiss Axiovert 200M microscope. ImageJ was then used to analyze the fluorescence 
intensity profiles. The plotted profiles confirm the formation of a well-defined, linear and 
stable concentration gradient as also reported in similar works (46). 
2.2.3. Primary neutrophil isolation 
Sodium Heparin (Fisher Scientific) anti-coagulated human blood was obtained 
from healthy volunteers according to approved Institutional Review Board (IRB) protocol 
12030. Neutrophils were isolated by density gradient centrifugation of a centrifuge tube 
containing 4 mL of whole blood layered over 4 mL of Cell Isolation Medium (Cedar Lane 
Labs). The isolated neutrophils were washed twice and resuspended to 107 cells/mL in 
Hank’s Balanced Salt Solution with 2% Human Serum Albumin and incubated at 37ºC 
following a previously reported protocol (48). 
2.2.4. Experimental procedure 
Cells were washed and suspended in modified Hank’s Balanced Salt Solution 
(mHBSS) containing 1% Human Serum Albumin (HSA).  The device was prepared by 
washing the channels with a 70% v/v ethanol solution.  The channels were then rinsed 
with PBS (phosphate buffered saline) and 30 μL of the neutrophil suspension (5 x 106 
cells/mL) was injected into the microfluidic device.  The device was next incubated for 
20 minutes to allow cells to adhere to the substrate. After incubation, the device was 
connected to a syringe pump and the desired combination of chemoattractant solutions 
(IL-8 and fMLP Sigma Aldrich, LTB4 Fisher Scientific) were infused into the device from 
separate inlets at a flow rate of 0.02 mL/hr to establish the desired concentration 
gradients. 
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2.2.5. Time-lapse microscopy and analysis 
Differential interference contrast (DIC) images were captured with a Zeiss 10X 
NA 1.30 DIC objective on a Zeiss Axiovert 200M microscope every 10 seconds. All 
images were captured with a cooled charge-coupled device camera (AxioCam MR3, 
Zeiss). Cells were then randomly selected from the image stack and manually tracked 
using ImageJ® (NIH) using the Manual Tracking plugin by Fabrice Cordelieres (Institut 
Curie, France). The plugin provided a way to tabulate the XY coordinates of each cell 
centroid in the temporal stack, as well as to obtain velocity and displacement 
measurements between successive frames. The resulting excel spreadsheets were 
then analyzed using custom Python scripts to yield cell trajectories, chemotactic indices, 
cell speeds and mean square displacements. We define the chemotactic index (CI) as 
displacement along the gradient direction (x) over the total migration distance (d), or CI 
= x/d, while the mean square displacement is defined as: MSD = <|r(t) - r(0)|2>. 
2.3. Results  
2.3.1. Persistent random walk in isotropic chemoattractant environments 
Activated neutrophils exhibit motion resembling that of a persistent random walk 
in isotropic chemoattractant environments, with directional correlation on the order of 
minutes (49). Figure 2.3 shows the upward migration of cells tracked in isotropic 
conditions of 25 nM fMLP, 25 nM IL-8 and 50nM LTB4 (based on the optimal 
sensitivities established from the single gradient experiments) against the buffer-only 
control. Note that the mean migration index was approximately zero in all cases. 
However, activated cells exhibited significantly greater variance than the control as 
would be expected. The plot of mean square displacements (MSD) also suggests 
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random walk-like behavior, as the slopes of each curve measured approximately one in 
a log-log plot of MSD against time. Activated cells were also shown to exhibit greater 
linear velocities than the control, indicating that activation is a requirement for motility.  
2.3.2. Chemotaxis in single chemoattractant gradients 
The chemotactic responses of cells toward single gradients of fMLP, IL-8, and 
LTB4 were analyzed by measuring the chemotactic index and average linear velocities 
of a subset of cells. In each case, linear concentration profiles of 0-10 nM, 0-25 nM and 
0-50 nM were applied across the 350 μm channel, with no gradient as the control. 
These conditions were chosen roughly for their ability to produce optimal chemotaxis. 
As evidenced by the positive mean chemotactic indices in Figure 2.4, most cells 
exhibited net migration up each attractant gradient. However, in each case the mean 
response appeared to vary according to the gradient condition. While the chemotactic 
index correlated weakly with the slope of the gradient [2-8, 20], the cells were most 
responsive to fMLP in the 0-10 or 0-25 nM range. For IL-8, cells responded optimally to 
the 0-25 nM gradient. Finally, for LTB4, cells were most responsive to the 0-50nM 
gradient. The linear velocities of these cells follow trends similar to the chemotactic 
index. The slope of the gradient does not directly correlate to the linear velocity. 
Additionally, the velocity of the cells was comparable at the different gradient conditions. 
Overall, the chemotactic responses toward the single chemoattractant gradients were 
similar to previous reports (24, 25, 32, 34, 36, 44, 45, 50). Moreover, we can conclude 
that the "Y-type" device appears to perform comparably well. 
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2.3.3. Response to single gradients superimposed over an alternate isotropic 
attractant field 
To study the effect of crosstalk in the chemosensory pathways, a single gradient 
was established over an isotropic background field. This was performed by adding the 
background chemoattractant equally to both inlets and creating the single gradient as 
done above. In the first case, an fMLP gradient was applied over isotropic fields of IL-8 
and LTB4 respectively. As shown in Figure 2.5, we find that increasing the background 
chemoattractant concentrations does not inhibit chemotaxis up the fMLP gradient in 
either case. This is in agreement with previous findings, where cells have been shown 
to migrate up end-target attractant (fMLP) gradients over other intermediary attractant 
fields (50). This apparent signaling hierarchy is maintained even when IL-8 and LTB4 
are introduced as linear gradients against an fMLP gradient. In another experiment, 
single gradients of the intermediary chemoattractants LTB4 and IL-8 were established 
over a uniform background of fMLP. We note that increasing the concentration of fMLP 
inhibited chemotaxis up either intermediary attractant gradient. Together with the 
previous result, this observation corroborates the existence of a signaling hierarchy 
between the two classes of chemoattractants, in which fMLP takes precedence over 
both IL-8 and LTB4 as previously described (50). 
In the last set of desensitization experiments, a single IL-8 gradient was 
established over a uniform background of LTB4, as well as the converse experiment 
under similar conditions. A negative correlation can be noted between the gradient 
magnitude and chemotactic index. However, relative to the migration efficiency in single 
gradients (Figure 2.4), the background attractant field appears to inhibit migration up 
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the gradient of the alternate intermediary chemoattractant. These results suggest that 
neither attractant takes precedence over the other in terms of a strong signaling 
hierarchy - instead, both species appear to attenuate the chemotactic efficiency toward 
the other in a relatively symmetric fashion.  
2.3.4. Oscillatory behavior in the opposing intermediary gradients 
Opposing linear intermediary attractant gradients (IL-8 vs. LTB4) were 
established within the microchannel. Primary cells introduced into the device were 
tracked for up to 80 minutes to analyze their individual behavior. The representative 
trajectories of cells under varying gradient conditions are shown in Figure 2.6.  The first 
thing to note is that in almost all cases, cells initially migrated against the local gradient 
of the proximal source to display "true" chemotaxis toward the distant agonist. That is, 
cells initially positioned in the upper half of the channel appeared to move toward the 
lower half and vice-versa, as previously documented (32). Over longer times, however, 
we note that these cells then undergo multiple directional changes, resulting in 
oscillatory trajectories meandering back and forth between the two maxima. Again, 
while it was previously speculated that cells would move in this manner, this is the first 
experimental confirmation of this hypothesis. It should also be noted that the 
magnitudes of the applied gradients were varied by two orders of magnitude in each 
chemoattractant, allowing for a broad range of conditions. However, the general trend 
appears similar in all cases, indicating a highly robust and stable response. 
To demonstrate that the oscillatory cell trajectories were not the result of random 
walk-like behavior as observed in isotropic conditions, we plot representative 
trajectories of the isotropic, single gradient and dual gradient cases side-by-side in 
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Figure 2.7. Unlike the cell trajectories in the uniform IL-8 environment, in which 
displacement along the channel width fluctuated around the initial starting position, the 
key thing to note in the dual gradient case is that the oscillations are centered around 
the channel median. This dissemblance is further shown quantitatively in Figure 2.8, 
where we counted the number of times the channel median was crossed by each cell. 
Prior to counting, the data was first pre-processed using state estimation via a standard 
Kalman filter with process noise variance set to 10-4 microns2. Here we see that the 
mean number of zero crossings is higher in the dual gradient experiments than in the 
control, despite the larger variance. This result suggests statistically that the oscillatory 
behavior of cells in the opposing gradients is not the result of the default, inherently 
random motion of foraging cells in isotropic conditions. 
2.3.5. Discussion 
Neutrophil chemotaxis is an important physiological process that occurs during 
immune defense and wound healing, yet the chemotactic response of these cells to 
multiple attractant gradients remains poorly understood. In this work we applied a 
microfluidic device to study, in particular, the behavior of primary cells under opposing 
gradients of the intermediary chemoattractants LTB4 and IL-8. Our findings extend 
previous reports that activated neutrophils not only seek the distant source in opposing 
intermediary attractant gradients, but also exhibit oscillatory behavior between the 
maxima over longer times. In addition, the results corroborate previous reports of 
neutrophil responses in varying chemoattractant conditions, showing that: (i) the 
intermediary chemoattractants IL-8 and LTB4 do not inhibit the response toward the 
end-target chemoattractant fMLP (indicating that the latter takes precedence in an 
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intracellular signaling hierarchy), and that (ii) IL-8 and LTB4 have a weak inhibitory effect 
on one another, but their effect is mutual (suggesting that no hierarchy is present for 
these intermediary cues).   
The theoretical repercussions of these findings are of particular interest - the 
robustness of this sustained oscillatory response strengthens the argument for a 
feedback-based mechanism in which cells transiently lock onto sensed targets through 
their pseudopodia. This switch-like mechanism is reminiscent of many processes in 
biology, particularly those pertaining to the careful spatial and temporal coordination of 
neutrophil chemotaxis in vivo that have recently come to light. While the exact 
intracellular network responsible for this feedback is unclear, this work presents a case 
against purely receptor-level mechanisms in describing the motion of cells in opposing 
intermediary attractant gradients. 
  
21 
 
2.4. Figures 
 
Figure 2.1. Schematic of microfluidic platform with Y-shaped channel.  The 
platform was comprised of a molded PDMS slab embossed with microchannels and 
bonded to a glass coverslip. 
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Figure 2.2. Cross-sectional concentration profile for single gradient. Gradient 
formation was verified by feeding a fluorescein-labeled solution into one inlet and an 
unlabeled solution into the other inlet of the device. The resulting fluorescence intensity 
profile confirms the formation of a well-defined, stable, linear concentration gradient. 
The normalized FITC concentration across the channel cross-section is shown. 
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Figure 2.3. Migration in isotropic attractant conditions. [A] Uniform chemoattractant 
environments were established by flowing the same solution into both channel inlets. 
Cells were tracked for 20 minutes in fMLP, IL-8 and LTB4, and the upward migration 
indices of 30 cells are shown here for comparison against the control (MHBSS buffer 
only). The selected concentrations are based on the estimated optimal sensitivities from 
prior experiments. [B] The mean square displacements (MSD) of the cells from the 
previous figure as a function of time. Cells were exposed to uniform concentrations of 
fMLP, IL-8 and LTB4. Note the slopes for the stimulated cells are approximately 1 in the 
log-log plot, indicating a random walk-like trajectory. [C] The average linear velocities of 
the cells from the previous figure. Again, cells were exposed to uniform concentrations 
of fMLP, IL-8 and LTB4. The observed average velocities of roughly 12 to 18 
microns/minute for activated cells are consistent with the literature. Note the cells 
appear to be slightly less responsive to LTB4. [D] Sample trajectories from the previous 
control experiments. [top left] MHBSS buffer only; [top right] 25nM fMLP; [bottom left] 
25nM IL-8; [bottom right] 50nM LTB4. 
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Figure 2.4. Chemotaxis in single attractant gradients. [A] Chemotactic indices in 
single attractant gradients. Neutrophils migrated toward higher concentration in all 
single linear attractant gradients, as indicated by the positive chemotactic indices. In 
each experiment, 30 cells were tracked for 20 minutes. Note that the cells were most 
responsive to fMLP in the 0-10 or 0-25nM range, while for IL-8, cells responded 
optimally to the 0-25nM gradient. For LTB4, the cells exhibited the greatest response to 
the 0-50nM gradient. [B]Average linear velocities of the cells from the single attractant 
gradient experiments. For each chemoattractant species, note that the magnitude of the 
gradient does not significantly affect cell speed. Moreover, the speeds are fairly 
consistent with those from the uniform concentration experiments. This suggests that 
the steepness of the gradient primarily affects the chemotactic bias, or accuracy of 
orientation, but does not influence the physical speed of activated cells. 
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Figure 2.5. Desensitization experiments. [A] Chemotactic index in a 0-25nM fMLP 
gradient over uniform intermediary chemoattractant concentration. The fMLP gradient 
was fixed for all conditions, while the concentration of the uniform intermediary 
attractant background was varied from 0 to 10nM for both IL-8 and LTB4. 30 cells were 
tracked for 20 minutes for each experiment. The correlation with the intermediary 
chemoattractant background concentration was weak, however, with Pearson 
correlations (r. 0.2715; P. 0.0027) and (r. -0.1153; P. 0.2096), respectively. [B] 
Chemotactic index in a 0-25nM fMLP gradient over an opposing intermediary attractant 
gradient. The fMLP gradient was fixed for all conditions, while the intermediary 
attractant gradient was varied from no gradient to 0-100nM for both IL-8 and LTB4. The 
correlation with the intermediary chemoattractant background concentration was weak 
with Pearson correlations (r. -0.1694; P. 0.1331) and (r. -0.1304; P. 0.1785), 
respectively. [C] Chemotactic index in 0-25nM IL-8 and 0-15nM LTB4 gradients over 
uniform fMLP. All conditions in the left figure consisted of a fixed 0-25nM IL-8 gradient 
over a uniform fMLP field, while all conditions on the right had a fixed 0-15nM LTB4 
gradient over uniform fMLP. The Pearson correlations were (r. -0.6412; P. 0.0000) and 
(r. -0.5687; P. 0.0000), respectively. This result corroborates the hypothesis that a 
signaling hierarchy exists between end-target and intermediary chemoattractant types. 
[D] Chemotactic indices for cells in intermediary chemoattractant gradients over uniform 
background concentration of alternate intermediary chemoattractant. All conditions in 
the left figure consisted of a fixed 0-15nM IL-8 gradient over a varying uniform LTB4 
background, while all conditions in the right figure consisted of a fixed 0-25nM LTB4 
gradient over a varying uniform IL-8 background. The Pearson correlations were (r. -
0.4069; P. 0.0001) and (r. -0.4414; P. 0.0000), respectively.  
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Figure 2.6. Sample cell trajectories in dual opposing intermediary 
chemoattractant gradients. Representative cell trajectories indicating the migration 
behavior of cells in dual opposing gradients of IL-8 and LTB4 of gradients ranging two 
orders of magnitude. 
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Figure 2.7. Sample cell trajectories under varying intermediary chemoattractant 
conditions. Representative cell trajectories indicating the migration behavior of cells in 
[A] isotropic conditions, [B] single intermediary attractant gradients, and [C] dual 
opposing gradients of IL-8 and LTB4. 
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Figure 2.8. Oscillatory behavior based on zero crossings. The cell trajectories were 
analyzed to count the number of times the channel centerline was crossed within each 
80 minute experiment. Noise was attenuated using state estimation via a standard 
Kalman filter with process noise variance set to 10-4 microns2. The first two columns on 
the left represent the single gradient controls for IL-8 and LTB4 respectively. Note that 
the means are higher in the dual gradient experiments than in the control, despite the 
larger variance. Thus, while some cells were not particularly motile, this plot 
corroborates the visual observation that cells exhibit oscillatory motion in dual 
intermediary chemoattractant gradients. 
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Chapter 3 
CELL SIGNALING 
3.1 Introduction 
Cells communicate via three unique mechanisms (1).  The first method is through 
gap junctions directly connecting the cytoplasms of two adjacent cells.  The directly 
connected cells allow molecules to diffuse freely between the two cells.  Second, direct 
contact between the two cells through adherens and tight junctions enables cells to 
transduce signals into and out of the cell.  The third method, paracrine and endocrine 
signaling through diffusible molecules, activates cell surface receptors.  Communication 
via diffusible molecules allows cells to communicate over long distances.  Intercellular 
communication can induce a cell to spring into action, secrete soluble signals, 
differentiate, or even undergo apoptosis.  An example of long range cell communication 
is the coordinated response of the innate immune system.  Macrophages are recruited 
to the site of injury or infection and secrete cytokines such as tumor necrosis factor 
(TNF) and interleukin-8 (IL-8) (2).  These cytokines then activate and recruit leukocytes 
to the desired site (3).  Stem cell proliferation and differentiation has also been found to 
be influenced by soluble molecules secreted by neighboring cells.  The complex 
signaling networks associated with paracrine and endocrine signaling are integral 
physiological processes in tissue and organ development, wound healing, 
tumorigenesis, and the immune response (4, 5). 
While the importance of studying cellular communication is evident, the 
conventional techniques are limited in studying this phenomenon (6).  The conventional 
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methods of studying cell communication through diffusible molecules include transwell 
assays, bolus transfer of conditioned medium, and co-culture experiments.  The 
limitations of these methods restrict the information gathered from cell communication 
experiments.  Specifically, in transwell assays one cannot control the spatial and 
temporal presentation of soluble molecules.  The bolus transfer of conditioned medium 
interferes with the natural gradient of signals, and in direct co-culture experiments one is 
unable to discern a specific cellular response from a specific signal.  Hence, a method 
that has control over the spatial and temporal presentation of molecules but still allows 
the signaling gradient to occur naturally is required. 
The use of microfluidic platforms to study biological processes has helped to 
address some of the shortcomings of conventional platforms (6).  Specifically, 
microfluidic platforms allow for precise control over cell seeding, culture, and the 
chemical microenvironment (7-10).  This control enables effective delivery of nutrients 
and soluble molecules as well as the placement of multiple cell types.  In addition, 
microfluidic platforms have relevant biological length scales (~100 μm).  These 
attributes of microfluidic platforms have allowed their use in studies of cell 
communication.  Specifically, methods to pattern cells inside microfluidic platforms to 
study cell signaling have been developed (9, 11, 12).  Others have developed 
microfluidic platforms to study cell migration under co-culture conditions (7, 13, 14), 
which have been studied extensively (15-19).  Meanwhile, others have developed 
microfluidic platforms to specifically study intercellular communication between two cell 
types (8, 20, 21).  However, these techniques are largely two dimensional, lack control 
over soluble molecule flow and gradient formation, or are limited to two cell types. 
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This chapter describes the development of two microfluidic platforms that permit 
the patterning of three different cell types encapsulated in biologically derived 3D 
scaffolds to study intercellular communication.  Specifically, Matrigel scaffolds are used 
to provide the cells a 3D structure on which to adhere.  The cells are encapsulated in 
the Matrigel scaffold and then patterned into separate channels requiring the cells to 
communicate over long distances (~100 μm).  The first microfluidic platform requires an 
initial supply of medium that must remain static, as introduction of fluid flow in the 
channels washes away the soluble molecules and thus prevents communication 
between separate cell types.  A second microfluidic platform was developed that allows 
a continuous supply of medium without washing away the soluble molecules.  Cell 
viability over long periods of time was tested in each of these devices to determine if 
these devices are suitable for experiments requiring long durations. 
3.2 Materials and methods 
3.2.1 Device fabrication and design 
The microfluidic platform comprised of a molded poly(dimethysiloxane) (PDMS, 
General Electric RTV 650 Part A/B) slab bonded to a glass substrate using standard 
soft lithography.  A high resolution printer (5080 dpi) was used to print a mask with the 
design pattern on a transparency film. The mask was used to fabricate approximately 
50 µm high SU-8 2050 photoresist (Microchem) features on a silicon wafer via 
photolithography.  PDMS molds with embossed channels were fabricated using soft 
lithography by curing the pre-polymer on the silicon master for 2 hours at 70ºC.  The 
PDMS replica was then peeled off the silicon master.  Inlets and outlets for the fluids 
and cells were created in PDMS using a 23 Gauge steel punch.  The surface of the 
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PDMS replica and a clean glass coverslip (Fisher Scientific) were treated with air 
plasma for 90 seconds (Model PDC-001, Harrick Scientific) and irreversibly bonded to 
complete the device assembly.  The device inlets were then connected to 1 mL syringes 
(BD Biosciences) with 23 G ¾ size needles (BD Biosciences) via PTFE tubing (Cole-
Parmer).  All syringes were calibrated and pushed by a constant pressure syringe pump 
(Harvard Apparatus).  
3.2.2 Cell culture and cell-cell communication model system 
Raw 264.7 (ATCC TIB-71) were cultured in DMEM medium (Sigma) 
supplemented with 10% fetal bovine serum (Gemini) and 100 U/mL 
penicillin/streptomycin (Gibco) at 37 C̊ and 5% CO2.  Cells were passaged at 80% 
confluence by mechanical dissociation with a cell scraper every 2-3 days.  HEK 293 
cells were cultured in DMEM medium supplemented with 10% fetal bovine serum and 
100 U/mL penicillin/streptomycin and incubated at 37 C̊ and 5% CO2.  Cells were 
passaged at 80% confluence by trypsinization (0.5% trypsin/EDTA) every 2-3 days.  
ATCC 25922 E. coli were grown in LB broth at 37 C̊, 5% CO2, and shaking culture until 
mid-logarithmic stage.  
Raw 264.7 cells were transfected with the TNF-ptimer vector using an Amaxa 
Nucleofector and nucleofector kit V (Lonza) according to manufacturer’s instructions.  
All plasmid DNA was isolated using an endotoxin-free plasmid isolation kit (Qiagen).  
Briefly, 2 μg plasmid DNA was transfected into 1x106 Raw 264.7 cells.  24-48 hours 
after transfection, 800 μg/mL g418 (Sigma) was added to the culture medium to select 
for positively tranfected cells.  The NFKB-GFP lentiviral vector was purchased from 
SABiosciences.  1x104 HEK cells were seeded into a 96 well plate and incubated with 
37 
 
polybrene and lentivirus at a mode of inheritance (MOI) of 20.  To generate stable HEK 
NFKB cell lines, cells were selected by the addition of 800 μg/mL puromycin (Sigma) 
starting 3-4 days post transduction. 
3.2.3 Experimental procedure 
All Matrigel (BD Biosciences) experiments were conducted in a cold room (4 C̊) 
to prevent premature gelation of the Matrigel solutions.  Cells were harvested by 
mechanical dissociation with a scraper or trypsinization and concentrated by 
centrifugation.  Cells were resuspended in serum free culture medium to the desired 
concentration and mixed with growth factor reduced Matrigel solution at a 20:80 (cell : 
Matrigel) v/v ratio.  Each cell suspension was injected into the desired inlet of the 
microfluidic device and incubated for 20 minutes at 37C̊ and 5% CO2 to allow for 
Matrigel curing.  A syringe pump inside the incubator was then connected to the device 
and medium was infused through the device at a flow rate of 0.02 mL/hr. 
Cell viability was assessed with the Molecular Probes live/dead assay kit 
(Invitrogen).  After the allotted culture time (18 hours), cells were washed with PBS and 
incubated with 2 μM Calcein AM and 2 μM Ethidium homodimer-1 fluorescent dyes for 
20 minutes.  Viability was assessed by counting the number of live (green) versus dead 
(red) cells.  Fluorescent images were taken with a Zeiss Axiovert 200M. 
3.3 Development of microfluidic platform 
Although microfluidic platforms are ideally suited to study endocrine signaling 
due to exquisite spatial control, the platform design should enable the cells to be viable 
over long periods of time (days).  Cell viability over long time periods is necessary 
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because the cells must first produce the signaling molecule which can require on the 
order of 10 hours.  Next, the signaling molecule must diffuse to the desired site where 
an appreciable amount of the molecule must begin to concentrate (~5 hours), and finally 
a phenotypic response by the receiving cell type will occur (hours to days).  In addition 
to cell viability, the device should not flush away the signaling molecules, i.e., the 
signaling molecules must be able to diffuse to each cell type through the device. 
3.3.1 Platform 1: Static medium microfluidic platform 
A microfluidic device (Figure 3.1) was fabricated following the procedure 
described previously (Section 3.2.1).  The posts fabricated into the microchannels of the 
device allow for control over the seeding of the cells.  A cell-Matrigel suspension was 
seeded into the channel furthest to the right, the middle channel, and the channel 
furthest to the left.  The two remaining channels were filled with medium to provide 
nutrients to the cells.  The medium filled channels separate the different cell types that 
enable the study of long-range communication. 
To confirm viability inside the device, a cell viability assay was performed 
following the procedure listed above (Section 3.2.3).  Fluorescent images of the cells 
are shown in Figure 3.2.  The live (green) and dead (red) cells were counted to 
determine cell viability in the device.  None of the cells were viable after 18 hours of 
incubation inside the microfluidic device.  The low cell viability in the static medium 
microfluidic platform may be related to either oxygen or medium deprivation.  Since 
PDMS is permeable to oxygen, the cell viability could be related to medium deprivation. 
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A syringe pump was connected to the microfluidic platform to determine if a 
continuous supply of medium affects cell viability.  Medium was pumped into the device 
at a rate of 0.02 mL/hr in the same two channels that previously contained medium.  
The cell viability assay was then performed following the same procedure (Figure 3.3).  
A cell viability of 75% was attained after 18 hours when a continuous supply of medium 
was introduced into the microfluidic platform.  The increased cell viability suggests that 
medium deprivation was causing cell death.  However, having medium continuously 
flowing through the microfluidic platform will wash away the signaling molecules.  
Hence, the platform must be redesigned to allow medium to continuously flow through 
the device without washing away the cell signaling molecules. 
3.3.2 Platform 2: Continuous medium microfluidic platform 
A second microfluidic device (Figure 3.4) was fabricated following the procedure 
described previously (Section 3.2.1).  A cell-Matrigel suspension was seeded into the 
channel furthest to the right, the middle channel, and the channel furthest to the left.  
The two remaining channels were filled with Matrigel.  The two channels separate the 
different cell types requiring them to communicate over long ranges.  A syringe pump is 
connected to the horizontal channel (bottom of the device) to provide a continuous 
supply of medium at a rate of 0.02 mL/hr.  From this channel, the medium is able to 
diffuse through the Matrigel and provide nutrients to the cells without directly washing 
away the signaling molecules.  For the cells to be viable over long periods in the 
microfluidic device, the rate of diffusion of the medium must be sufficiently high for cell 
viability. 
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A cell viability assay was performed following the procedure listed above (Section 
3.2.3).  The assay will primarily determine if the rate of medium diffusion through the 
Matrigel is sufficient for cell viability.  The live and dead cells from the viability assay are 
shown in Figure 3.5.  A viability of 91% was achieved after incubation in the continuous 
medium flow microfluidic platform for 18 hours.  The high cell viability in the platform 
suggests that the cells will continue to be viable in the device as long as fresh medium 
is continuously being supplied. 
3.4 Conclusion 
This chapter describes the design, fabrication, operation, and application of two 
microfluidic platforms to study endocrine signaling.  In the static medium platform, cells 
were not viable after 18 hours of incubation without medium continuously flowing 
through the device.  To determine the cause of cell death, medium was continuously 
pumped through the platform during incubation.  With the continuous medium supply 
cell viability increased drastically to 75% viability.  However, the continuous supply of 
medium would wash away any signaling molecules the cells secrete, hence a new 
device was designed. 
A second platform was designed to have a continuous supply of medium without 
washing away the signaling molecules.  The continuous medium platform attained high 
cell viability after incubation for 18 hours.  High cell viability is required to perform 
quantitative studies of endocrine signaling over long periods of time.  The continuous 
medium platform allows for quantitative biological studies to be performed going 
forward.A key advantage of the continuous medium platform is the precise patterning of 
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cells inside the device.  In addition, the patterned cells are viable over long periods of 
time (18 hours) and can signal each other via diffusible molecules.  Hence, the platform 
enables study of cell-cell behavior over long periods of time.  
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3.5 Figures 
Inlets
Outlets 300 um
 
Figure 3.1.  Schematic illustration of the static medium microfluidic platform.  Three different cell 
types can be added independently in this platform. 
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Figure 3.2. Cell viability using the static medium microfluidic platform with (a) HEK cells and (b) 
RAW cells.  Cells appearing red are dead and those appearing green are alive.  None of the 
cells were viable after 18 hours of incubation. 
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Figure 3.3. Cell viability assay using the static medium microfluidic platform with continuous 
flow of medium with (a) HEK cells and (b) RAW cells.  Cells appearing red are dead and those 
appearing green are alive.  Viability of 75% was achieved after 18 hours of incubation. 
  
45 
 
Medium Inlet
Medium Outlet
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Hydrogel Inlets
300 um
 
Figure 3.4.  Schematic illustration of the continuous medium microfluidic platform.  Medium can 
continuously flow through this platform without washing away diffusible signaling molecules. 
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Figure 3.5. Cell viability assay using continuous medium microfluidic platform with (a) HEK cells 
and (b) RAW cells.  Cells appearing red are dead and those appearing green are alive.  A 
viability of 91% was achieved after 18 hours of incubation. 
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Chapter 4 
CONCLUDING REMARKS 
4.1 Summary 
This thesis reported the development and use of microfluidic platforms to 
address challenges in studying neutrophil chemotaxis and intercellular signaling via 
soluble molecules.  During neutrophil chemotaxis, previous studies have shown that 
activated neutrophils preferentially migrate toward the more distant source in opposing 
linear intermediary chemoattractant gradients (interleukin-8 and leukotriene B4).  In 
addition, cells respond to the vectorial sum of the local gradients in the presence of two 
point sources. In this work, we demonstrate that primary neutrophils exhibit oscillatory 
motion between the maxima of opposing linear intermediary chemoattractant gradients 
if the experiments are conducted over longer periods.  Increasing the length of the 
experiments from 20 minutes to 80 minutes allows the cells to exhibit the oscillatory 
motion.  In addition, coupling this experimental data with a generalized model of 
neutrophil motility, one can argue that basic sensory adaptation may be insufficient to 
explain these phenomena. 
In addition to the study of neutrophil chemotaxis, this thesis reported the design, 
fabrication, and validation of a microfluidic platform to study intercellular signaling via 
diffusible molecules.  The microfluidic platform was designed to allow cells to be seeded 
independently, enabling flexibility during the cell studies.  In addition, the generation of 
signaling molecule gradients is unaffected by the operation of the microfluidic platform.  
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Finally, a cell viability of 91% was achieved after 18 hours of incubation inside the 
microfluidic platform. 
4.2 Future work 
We are currently studying endocrine signaling using a model biological system 
that mimics the innate immune response (Figure 4.1).  In the model system, 
Lipopolysaccharide (LPS) is released from the cell membrane of E. coli (ATCC TIB-71) 
and stimulates mouse macrophage cells (RAW 264.7).  Once stimulated, the 
macrophage cells fluoresce and secrete tumor necrosis factor (TNF).  The TNF is then 
bound to the TNF receptor on human embryonic kidney cells (HEK 293) and the cells 
fluorescently respond.  We aim to study the dynamics of the cell signaling cascade 
inside of the microfluidic platform described in Chapter 3. 
Future efforts in studying neutrophil chemotaxis are directed at the notion of 
intermediary chemoattractants (IL-8 and LTB4) as an intermediary network of sources 
involved in the long-range navigation of neutrophils.  Specifically, we are interested in 
studying the ability of neutrophils to move between intermediary sources while avoiding 
stagnation.  These studies will be performed by generating multiple alternating “hill-type” 
gradients of intermediary chemoattractants.  Finally, we seek to improve the 
understanding of neutrophil response to dynamically changing gradients.  
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4.3 Figures 
 
Figure 4.1.  Schematic illustration of the model biological system mimicking the innate immune 
response to a bacterial infection. 
